Isodiol closes $25 mln convertible debenture financing

Isodiol International Inc has raised a convertible debenture financing of $25 million from Alumnia Partners, a U.S. private equity firm. Based in Vancouver, Isodiol is a developer of pharmaceutical and nutraceutical grade cannabis compounds and maker of cannabis consumer products. Its products include hemp-derived skin care applications. Isodiol will use the funds raised to continue expansion into Latin American, Asian and European markets and pursue strategic acquisitions. The company is led by CEO Marcos Agramont.

DealsCanadaNorth AmericaBriefs